SLAMF1 and type 1 diabetes mellitus: Patients with L-T1D also had elevated plasma levels of SLAMF1 compared with HC (p = 0.002) and the AD group (p = 0.02), whereas SLAMF1 was more abundant in plasma from patients with HT than from HC (p = 0.049, Figure 1B).